Neonatal exposure to estrogens is known to cause delayed effects, a late-occurring adverse effect on adult female reproductive functions, such as early onset of age-matched abnormal estrous cycling. However, the critical period in which neonates are sensitive to delayed effects inducible by exogenous estrogen exposure has not been clearly identified. To clarify this window, we examined the intensity and timing of delayed effects using rats exposed to ethynylestradiol (EE) at various postnatal ages. After subcutaneous administration of a single dose of EE (20 lg/ kg, which induces delayed effects) on Postnatal Day (PND) 0, 5, 10, or 14 in Wistar rats, hypothalamic and hormonal alterations in young adults and long-term estrous cycling status were investigated as indicators of delayed effects. In young adults, peak luteinizing hormone concentrations at the time of the luteinizing hormone surge showed a decreasing trend, and KiSS1 mRNA expression of the anterior hypothalamus and number of KiSS1-positive cells in the anteroventral periventricular nucleus were significantly decreased in the PND 0, 5, and 10 groups. The reduction in KiSS1 mRNA and KiSS1-postive cells was inversely correlated with age at time of exposure. These groups also exhibited early onset of abnormal estrous cycling, starting from 17 wk of age in the PND0 group and 19 wk of age in the PND5 and 10 groups. These indicators were not apparent in the PND14 group. Our results suggest that PND0-PND10 is the critical window of susceptibility for delayed effects, and PND14 is presumed to be the provisional endpoint of the window.
INTRODUCTION
Exposure to various estrogenic chemicals during critical periods of development is widely known to cause irreversible damage to the programming of hypothalamus-pituitary-gonadal (HPG) axis in a wide range of species, leading to persistent impairment of and various adverse effects on reproductive functions later in life [1, 2] . Neonatal exposure to large amounts of estrogenic compounds has a serious influence on the sexual differentiation of the brain, causing various irreversible abnormalities, such as masculinized sexual behavior, malformation of the reproductive tract, and cessation of cyclic ovulation, effects commonly known as masculinization or defeminization [3] [4] [5] . On the other hand, shorter and lowerdose exposures also cause multiple adverse effects on female reproductive functions, but the timing and types of effects are reported to be different from those observed in masculinization. For instance, neonatal exposure to chemicals such as p-toctylphenol, methoxychlor, and the synthetic estrogen diethylstilbestrol (DES) is reported to induce early onset of agematched abnormal estrus cycling, advanced reproductive senescence, and increased uterine carcinogenic risk in young adult or aging rats [2, 6, 7] . These late-occurring effects that develop after the pubertal period are known as delayed effects or delayed reproductive dysfunction in previous reports [7] [8] [9] [10] .
Previously, we investigated delayed effects caused by neonatal exposure to single, relatively low doses of 17a-ethynylestradiol (EE) in rats [8, 11, 12] . EE is one of the synthesized estrogens widely utilized in the study of endocrine disruption and is known to have the characteristics of rapid excretion and lower binding affinity for a-fetoprotein in neonatal blood [13] . Because these characteristics were suitable for limiting exposure time and penetrating the blood-brain barrier, EE was thus selected as the model compound. In these studies, we revealed that the prior attenuation of the luteinizing hormone (LH) surge and reduction of KiSS1 mRNA levels in the hypothalamic kisspeptin neurons occur approximately 2 mo earlier than the onset of abnormal estrous cycling, suggesting that these alterations could be early indicators of delayed effects [11] . In the rat brain, kisspeptin neurons are located mainly in the anteroventral periventricular nucleus (AVPV) and arcuate nucleus (ARC), and each of these areas is considered to play a site-specific role: the AVPV triggers secretion of gonadotropin-releasing hormone (GnRH)/LH surge leading to ovulation, and the ARC provokes GnRH pulsatile secretion, which is responsible for follicular development [14] [15] [16] . In fact, attenuated KiSS1 expression in the AVPV and reduced amplitude of LH surge are reported to synchronize in middle-aged rats [17, 18] , and the circadianregulating function of AVPV KiSS1 expression, which may direct or indirectly control the timing of the LH surge, was also implicated in previous reports [19, 20] . These indicate the critical roles of AVPV KiSS1 signals in the regulation of physiological aspects of the LH surge and subsequent reproductive functions mediated by LH; therefore, it could be said that the AVPV-specific KiSS1 depression and reduced LH surge observed in our previous study might be an early key event in serial, late-occurring reproductive dysfunction in delayed effect.
Sexual differentiation of the central nervous system (CNS) is a crucial process for the establishment of the hypothalamic neural network and attainment of various reproductive functions in adulthood. This process generally occurs early in life; late embryonic to early postnatal ages are relevant in mammals, consistent with the period during which fetuses and neonates are exposed to endogenous maternal or their own gonadal hormones for proper development [21, 22] . Therefore, inappropriate exposure to estrogenic chemicals during this critical period could disrupt sexual differentiation and adult reproductive functions. However, the precise window during which the fetal or neonatal brain is sensitive to estrogen exposure has not been clearly defined. Yoshida et al. [6] reported that the subcutaneous injection of p-t-octylphenol during both Postnatal Day (PND) 1-5 and 1-15 induced the early onset of abnormal estrous cycling (persistent estrus) in young adult Donryu rats; however, the time needed for persistent estrus to develop in all animals within the group was shorter in the PND1-PND15 group (1.5 mo) than in the PND1-PND5 group (6 mo). Another study has shown that a single injection of estradiol valerate (EV) at PND14 induced severe cycle disruption starting at PND50 in Wistar rats, and the frequency of cycling during the period from PND 71 to 90 was reduced by 72% in prepubertal, EV-treated rats compared to rats in the control group [23] . These results indicate that the critical window of sensitivity in neonatal brains might extend to late postnatal ages, after the completion of CNS sexual differentiation [24, 25] ; however, to our knowledge, studies that intend to directly determine the critical window of postnatal sensitivity to estrogens have not been performed in the past, and whether there is a clear endpoint for the critical window remains unknown.
In the present study, to clarify the critical window of sensitivity to estrogenic compounds for delayed effects in rats, we investigated and compared the intensities and timing of delayed effects induced by a single subcutaneous injection of EE at PND 0, 5, 10, and 14. We examined 1) artificially induced LH surges and KiSS1 mRNA expression at 11 wk of age in the AVPV and ARC and 2) the long-term estrous cycling status until 40 wk of age; these parameters have previously been shown to be early and late indicators, respectively, of delayed effects [8, 11] .
MATERIALS AND METHODS

Animal Treatment and Chemicals
Pregnant Wistar Hannover GALAS rats were obtained from CLEA Japan, Inc. at Gestational Day 14 (n ¼ 37) in order to obtain female neonates for the experiments. The dams and their offspring were housed individually in polycarbonate cages with wood chip bedding and maintained in an airconditioned animal room (248C 6 18C; relative humidity, 55% 6 5%; 12L:12D) with a basal diet (CRF-1; Oriental Yeast Co.) and tap water available ad libitum. CRF-1 is a standard diet that includes soy protein and is known to contain a relatively low level of estrogens. All the neonates were randomized within 24 h after birth, and 10 neonates were allocated to each dam with a female predominance in order to exclude genetic biases. After randomization, dams were assigned to five groups (seven to eight dams/group). Neonates in each group received a single subcutaneous injection of sesame oil at PND0 (control group) or EE 20 lg/kg at PND 0, 5, 10, or 14 (referred to as group PND0, PND5, PND10, and PND14, respectively). EE (CAS No. 57-63-6; purity . 98%) was purchased from Sigma. The dose of EE selected for injection was capable of inducing delayed effects with reference to a previous report [8] . On PND21, the rats were weaned, and 30 female rats per group were housed two to four per cage. Starting on PND23, we checked for vaginal opening (VO) every day; the day of VO and body weight on the day of VO were recorded. After checking for VO, estrous cycle was monitored by vaginal smear for five consecutive days every week, and observations of clinical signs, body weight, and mortality were made throughout the experiment. The animal protocol was reviewed and approved by the Animal Care and Use Committee of the National Institute of Health Sciences (Japan).
Animal Treatment for Short-Term Analysis in Young Adults
A total of 10 out of 30 rats were used for the short-term analysis. At 10 wk of age, rats with normal estrous cycles received an ovariectomy (OVX) under isoflurane anesthesia. One week after OVX, all the animals were subcutaneously treated with 2 lg of estradiol benzoate at 0900 for three consecutive days and 500 lg of progesterone (P4) at 1100 of the last day of estradiol benzoate treatment for artificial LH surge priming. All the animals were decapitated (n ¼ 5/group) or transcardially perfused with 4% paraformaldehyde (PFA) (Nacalai Tesque, Inc.) under deep anesthesia with pentobarbital sodium (Kyoritsu Seiyaku Corporation) (n ¼ 5/group) between 1600 and 1700 of the surge priming day. In decapitated animals, blood samples were collected for serum hormone measurement, and hypothalami were dissected out for real-time PCR analysis as described in a previous report [11] . Dissected hypothalami were macroscopically divided using the optic chiasm as a boundary into anterior and posterior hypothalamus, which included the AVPV and the ARC, respectively. The hypothalamic samples were immediately frozen in liquid nitrogen and stored at À808C until the time of RNA isolation. For perfused animals, brains were removed immediately and postfixed in 4% PFA overnight at 48C, then immersed in 20% sucrose/PBS solution at 48C until the tissues sank. The fixed brains were embedded in optimal cutting temperature compound (Sakura Finetek Japan Co. Ltd.) and stored at À808C until sectioning. In all cases, uteri and vaginas were also resected. These tissues and ovaries removed by OVX were fixed in 10% neutral buffered formalin and routinely processed and stained with hematoxylin and eosin (HE) for histopathological examination.
Long-Term Observation of Estrous Cycle
A total of 16 out of 30 rats in each group were maintained until 40 wk of age for the long-term monitoring of estrous cycles. A decision on the cycle pattern was made with every 5-day observation. Regular 4-or 5-day cycles were deemed normal cycles, and other patterns were uniformly judged to be abnormal estrous cycles. In particular, animals showing proestrus or estrus continuously for 5 days or showing diestrus or metestrus continuously for 5 days were designated as having persistent estrus or persistent diestrus, respectively. Estrous cycles were recorded every week throughout the experiment. At 40 wk of age, all the animals were necropsied under isoflurane anesthesia, and the ovaries, uteri, and vaginas were resected from each animal. The weight of the ovary and uterus were also recorded. All the organs were fixed in 10% neutral buffered formalin and routinely processed and stained with HE for histopathological examination.
Quantitative Real-Time PCR Total RNA was extracted from the hypothalamus lysates using ISOGEN (Nippon Gene Co. Ltd.), and reverse transcription reactions were performed using 1 lg of total RNA with High Capacity Reverse Transcription kits (Applied Biosystems). Following the manufacturer's instructions, real-time PCR (7900HT Fast Real-time PCR System; Applied Biosystems) was performed using TaqMan Fast Universal PCR Master Mix (Applied Biosystems) and TaqMan Gene Expression Assays (Applied Biosystems) as primer-probe sets for the following genes: Kiss1 (KiSS1, Rn00710914_m1), Kiss1r (KiSS1R, Rn00576940_m1), and Gnrh1 (GnRH, Rn00562754_m1). The expression level of each gene was calculated by the relative standard curve method and normalized against endogenous GAPDH (TaqMan Rodent GAPDH Control Reagent; Applied Biosystems).
ICHIMURA ET AL.
Sectioning and Quantitative Analysis of KiSS1 mRNAPositive Cells in In Situ Hybridization
In order to evaluate the whole area of the AVPV and ARC, we made sequential coronal sections (20 lm thick) of the AVPV from approximately 0.12 mm anterior to 0.36 mm posterior to the bregma, and of the ARC from approximately 1.92 mm posterior to 3.72 mm posterior to the bregma [26] using a cryostat (CM1850UV; Leica). After sectioning, all the tissue sections were immediately mounted on coated slides (Matsunami Glass Ind., Ltd.) and then completely air dried and stored at À808C until staining. Because one section from every six sections from the AVPV and every 15 sections from the ARC was utilized for KiSS1 in situ hybridization (ISH), a total of four sections for the AVPV and six sections for the ARC per rat were examined to quantitate KiSS1-positive cells. For positive cell counting, an Olympus BX51 microscope with an Olympus digital camera DP73 (Olympus) was utilized, and all KiSS1-positive cells with visible reactions observed in the left half of the brain were manually counted at high magnification in a blinded fashion. The total numbers of KiSS1-positive cells in each group were statistically compared. It was confirmed preliminarily that all sections from the AVPV and ARC had approximately the same numbers of positive cells in each brain half.
ISH
Nonradioactive ISH was used for KiSS1 mRNA-positive cell detection. Slides were washed with PBS and treated with 1 lg/ml proteinase K (Takara Bio Inc.), followed by a brief 1% PFA immersion. After washing in PBS, slides were incubated with 0.25% acetic anhydride in 0.1 M triethanolamine and then prehybridized with hybridization buffer for 30 min. After prehybridization, slides were hybridized with 0.5 lg/ml of digoxigenin-labeled antisense RNA probe (sequence position 3-358, GenBank accession No. AY196983.1; Genostaff, Japan) overnight at 608C. A sense RNA probe was used as a negative control. Following hybridization, the slides were washed with 43 SSC (Roche Applied Science)/50% formamide, 23 SSC, and 13 SSC. Between SSC washes, slides were briefly immersed in a 20 lg/ml RNase working solution at 378C. After washing, slides were blocked with 2% bovine serum albumin (Sigma) in ISH buffer-1 and incubated with anti-digoxigenin antibody (1:1000; Roche Applied Science, Mannheim, Germany) in ISH buffer-1. Following washing with ISH buffer-1, the slides were immersed in ISH buffer-3 (100 mM Tris-HCl, pH9.5, 100 mM NaCl, and 50 mM MgCl 2 ) and then incubated with nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate solution (Roche Applied Science) in ISH buffer-3 for 2 h.
Hormone Assays
Serum samples obtained from decapitation were stored at À808C before assay. The serum concentrations of follicle-stimulating hormone (FSH) and LH were determined using double-antibody radioimmunoassays and 125I-labeled radioligands. National Institute of Diabetes and Digestive and Kidney Disease radioimmunoassay kits were used for rat FSH and rat LH with anti-rat FSH-S-11 and anti-rat LH-S-11 (National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, MD), as described previously [27] . The intra-and interassay coefficients of variation were 4.01% and 16.71% for FSH and 3.27% and 17.74% for LH, respectively.
Investigation of Histopathology and Immunohistochemistry at VO
To investigate treatment-related histopathological changes in the female reproductive organs at VO, four out of 30 rats in each group were used. Because acceleration of VO was observed in PND 10 and 14 groups, animals in these groups were necropsied on the next day of respective days of VO under isoflurane anesthesia, and the ovaries, uteri, and vaginas were resected from each animal. In the control, PND 0 and 5 groups without acceleration of VO, animals were necropsied at similar ages (in days) before VO to compare agematched histology of these tissues. All the organs were fixed in 10% neutral buffered formalin and routinely processed and stained with HE for histopathological examination. For immunohistochemistry (IHC), serial sections of vaginas were subjected to IHC for ERa. Anti-ERa antibody (1:1000, sc-542, MC-20; Santa Cruz Biotechnology Inc.) was used as a primary antibody, and the sections were visualized with 3,3 0 -diaminobenzidine using the Vectastain Elite ABC kit (Vector Laboratories Inc.). The percentage of ERa-positive cells in vagina was assessed with reference to previous report [12] . The percentage was judged separately in epithelial and stromal cells and scored as follows: 0, negative; 1, slightly positive (,20%); 2, partly positive (20%-50%); 3, positive more than half (50%-80%); and 4, mostly positive (.80%). The average score was calculated by observation of 10 randomly selected areas at 200-fold magnification.
Statistical Analysis
Following Bartlett's test, variances in data for the day of VO, body and organ weight, hormone level, real-time PCR, number of KiSS1-positive cells and score of ERa expression were compared with those for the control group by one-way analysis of variance or the Kruskal-Wallis test. When statistically significant differences were detected, the Dunnett multiple comparison test was employed for comparisons between the control group and the EE-exposed groups. The percentages of normal estrous cycling were compared by the Fisher exact test. In these tests, the level of significance was set at 0.05.
RESULTS
Clinical Observation, Body Weight, and VO
No deaths or abnormal clinical findings were observed during the experiment period. No treatment-related changes were detected in body weight. Mean day of VO and body weight on the day of VO are shown in Table 1 . As compared to the control group, the mean day of VO was significantly earlier in the PND 10 and 14 groups (P , 0.001 in both groups vs. control group), and mean body weight on the day of VO was also significantly decreased in these two groups (P , 0.001 in both groups vs. control group).
Long-Term Observation of Estrous Cycle
The sequential changes in the percentage of animals showing normal estrous cycle in each group are summarized in Figure 1 . In the control group, almost all the animals showed 4-or 5-day cycles until 29 wk of age. Thereafter, the number of animals presenting abnormal cycles gradually increased, and the percentage of animals with normal cycles decreased to 43.8% at 40 wk of age. In contrast, the percentages in the PND 0, 5, and 10 groups gradually decreased starting from an earlier age; the first statistically significant decreases in percentages were detected at 17, 19, and 19 wk of age in the PND 0, 5, and 10 groups, respectively. Regarding the differences among the EEexposed groups, the PND0 group showed the most rapid decrease, and statistical significant differences were observed through Wk 21-29 versus PND5 and/or PND10 groups. PND 5 and 10 groups showed nearly the same pace of decline and statistical significant differences versus PND14 group were detected in several time points until Wk 40. The percentage in the PND14 group was comparable to that of the control group until 25 wk of age and then showed a gradual decrease slightly earlier than the control group, but statistical significance was not observed between these two groups. Slight prolongation of the estrous cycle (such as 6-day cycle) frequently observed at the beginning of the cycle disruption was considered as abnormal 
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cycle in the present study, and thus recoveries of the percentage were occasionally observed throughout the experimental period. These animals finally turned out to present persistent estrus or diestrus in most cases.
Quantitative Real-Time PCR for KiSS1 and Related Genes
KiSS1 mRNA expression in the anterior and posterior hypothalamus (i.e., AVPV and ARC, respectively) at the time of the LH surge is presented in Figure 2 . Relative expression levels of KiSS1 in the AVPV (mean 6 SD) were 1.00 6 0.22, 0.54 6 0.06, 0.61 6 0.13, 0.76 6 0.12, and 0.83 6 0.12 in the control, PND 0, 5, 10, and 14 groups, respectively. In the AVPV, the relative expression levels of KiSS1 mRNA were significantly decreased in the PND 0, 5, and 10 groups compared to those in the control group (P , 0.001, , 0.001, and ¼ 0.047 vs. control group, respectively), and the decrease was inversely correlated with age at exposure. Although no statistical significance was found, the KiSS1 mRNA expression level in the PND14 group was also slightly decreased compared to that of the control group (P ¼ 0.20 vs. control group). Relative expression levels of KiSS1 in the ARC (mean 6 SD) were 1.00 6 0.17, 0.84 6 0.19, 0.73 6 0.19, 0.94 6 0.12, and 0.99 6 0.09 in the control, PND 0, 5, 10, and 14 groups, respectively. In the ARC, a significant decrease in KiSS1 mRNA expression was detected in the PND5 group (P ¼ 0.049 vs. control group), but no change was observed in any other group. The mRNA expression of KiSS1-related genes (GnRH1 and KiSS1R) were also analyzed in the present study. Although a significant decrease in KiSS1 mRNA expression in the AVPV was detected in the PND 0, 5, and 10 groups, mRNA expression of GnRH1 and KiSS1R was not significantly different between the EE-exposed and control groups in the AVPV (data not shown).
ISH for KiSS1 in the AVPV and ARC
Representative images of KiSS1-positive cells in the AVPV and ARC are presented in Figures 3 and 4 , respectively. Clear blue-violet-positive reactions for KiSS1 mRNA were detected around the third ventricle (3V). The number of KiSS1-positive cells in the AVPV (mean 6 SD) were 164.0 6 35.6, 90.4 6 17.1, 116.8 6 14.8, 123.8 6 15.1, and 156.3 6 11.0 in the control, PND 0, 5, 10, and 14 groups, respectively. In the PND0 group, visible reactions for KiSS1-positive cells were clearly diminished in number in the AVPV, and the total number of KiSS1-positive cells (half brain) in this group was significantly decreased compared to that of the control group (P , 0.001 vs. control group). Expression of KiSS1 mRNA was also diminished in PND5 and 10 groups; the total number of KiSS1-positive cells was also significantly decreased in these groups (P ¼ 0.009 and ¼ 0.037 vs. control group, respectively). In the PND14 group, no significant difference was found in total number of KiSS1-positive cells when compared to that of the control group. Similar to the results obtained from real-time PCR and long-term estrous cycle analysis, the decrease in the number of KiSS1-positive cells detected by ISH also was inversely correlated with age at exposure. The number of KiSS1-positive cells in the ARC (mean 6 SD) were 208.6 6 48.7, 156.8 6 32.8, 159.6 6 68.7, 224.6 6 21.6, and 214.2 6 58.0 in the control, PND 0, 5, 10, and 14 groups, respectively. In the ARC, slight decreases in the number of KiSS1-positive cells were observed in the PND 0 and 5 groups, but no statistical significance was detected in these groups (P ¼ 0.30 and ¼ 0.34 vs. control group, respectively).
Serum Concentration of LH and FSH
Serum concentrations of LH and FSH at the peak time of the LH surge are shown in Figure 5 . All the blood samples were collected by decapitation during the interval 1600-1700, corresponding with the peak time of the LH surge under our laboratory conditions [11] . Serum LH concentrations (mean 6 SEM) were 11.64 6 3.87, 5.56 6 2.56, 6.73 6 2.07, 2.70 6 0.95, and 10.32 6 2.51 ng/ml in the control, PND 0, 5, 10, and 14 groups, respectively. The peak concentration of LH showed a decreasing trend in the PND 0, 5, and 10 groups, however, statistical significances were not detected (P ¼ 0.30, ¼ 0.48, and ¼ 0.07 vs. control group, respectively). On the other hand, the peak LH concentration in the PND14 group was ICHIMURA ET AL. comparable to that of the control group (P ¼ 0.99 vs. control group). FSH concentrations (mean 6 SEM) were 19.25 6 2.40, 13.36 6 2.35, 20.44 6 1.94, 14.23 6 3.48, and 28.80 6 1.68 ng/ml in the control, PND 0, 5, 10, and 14 groups, respectively. Concentration of FSH in the PND14 group showed an increasing trend (P ¼ 0.06 vs. control group), but statistically significant changes were not observed including other experimental groups.
Pathology of the Female Reproductive Tract at 40 wk of Age
The weights of uteri and ovaries at 40 wk of age are presented in Table 2 , and representative histologies of ovaries at the same ages are presented in Figure 6 . Both the absolute and relative weights of ovaries at 40 wk of age were significantly decreased in the PND 0, 5, and 10 groups compared to those of the control group (P ¼ 0.012, , 0.001, and ¼ 0.005 in the absolute weight and ¼ 0.020, ¼ 0.007, and ¼ 0.018 in the relative weight vs. control group, respectively). Corresponding to the decrease in ovarian weight, most ovaries in these groups presented moderate to severe atrophy, increased number of follicular cyst, and decreased number of corpora lutea (CL) in the ovary. In contrast, most animals in the control and PND14 groups had large, solid CL and small-to mediumsized antral follicles, meaning that a number of animals maintained estrous cycles until this age in these groups. In other organs examined, there was no significant histopathological finding.
Histopathological and Immunohistochemical Investigation of VO
Representative images of ovarian histology and vaginal IHC in the control group (without acceleration of VO) and PND14 group (with acceleration of VO) as well as the scores of ERa expression are presented in Figure 7 . The animals were necropsied on PND24-PND27 (the day after the day of VO) in the PND10 and PND14 groups and on PND25 or PND27 (before VO; two rats on each day) in the control and PND0 and PND5 groups. In the PND10 and PND14 groups, formation of new CL (evidence for the first ovulation) was not found in the ovary, and no other histological changes were detected in the ovaries, uteri, and vaginas. For further investigation, we performed IHC for ERa in vaginas. The scores of ERa expression in the vaginal epithelium (mean 6 SD) were 3.88 6 0.10, 3.90 6 0.14, 3.93 6 0.10, 3.93 6 0.10, and 3.90 6 0.12 and in the stroma were 2.78 6 0.30, 2.80 6 0.18, 2.78 6 0.10, 2.53 6 0.26, and 2.70 6 0.16 in the control, PND 0, 5, 10, and 14 groups, respectively. No statistical significance was detected and the scores of ERa expression were comparable in all groups regardless of VO status.
DISCUSSION
In the present study, postnatal exposure to EE at 20 lg/kg at PND 0, 5, and 10 decreased KiSS1mRNA expression and the number of KiSS1-positive cells at 11 wk of age, indicating that the critical window of sensitivity to EE for the development of delayed effects is maintained up to PND10 in rats. Hypothalamic kisspeptin neurons are now widely recognized as central regulators of various female reproductive functions, and the AVPV is known to play critical roles in the regulation of estrous cycling [14, 28] . Therefore, the down-regulation of KiSS1 mRNA in the AVPV in the present study means that there is a reduction in neurotransmission in the HPG axis at the time of the LH surge, suggesting attenuated reactivity of kisspeptin neurons to exogenous estrogenic treatment, such as LH surge priming. In fact, in association with the decrease in KiSS1 mRNA expression, an attenuating trend of the LH surge was also observed in these groups, indicating that diminished expression of KiSS1 mRNA leads to the reduction in LH release in the pituitary. Although the results of LH concentration lack the statistical support due to the small sample size in the present study, similar results were confirmed in a previous study using lager number of animals and time points [11] . These serial alterations in KiSS1 expression and LH surge in the PND 0, 5, and 10 groups indicate that EE exposure at these ages could influence the development of kisspeptin neurons, consequently causing delayed effects at later ages. Consistent with the groups with diminished KiSS1 mRNA expression and LH surges, the PND 0, 5, and 10 groups showed early onset of Expression levels in each group are normalized to GAPDH levels, and the level of the control group is adjusted to 1.0. Symbols indicate significant differences from the control group (*P , 0.05 and **P , 0.01 by Dunnett test).
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age-matched abnormal estrous cycling, which was reported to be a sensitive and established indicator of delayed effects [8] . Atrophic ovary accompanying increased follicular cyst formation and decreased CL in these groups are considered to reflect long-term cessation of the estrous cycle. It is notable that all of these alterations were observed in the same PND 0, 5, and 10 groups, once again suggesting that the developing hypothalamus maintains sensitivity to exogenous estrogen exposure until late postnatal ages.
Another important finding in the present study is an agedependent decrease in sensitivity to postnatal estrogen exposure. In the PND0 groups, early onset of abnormal estrous cycling started at 17 wk of age, and this result is mostly consistent with our previous study [8] . The PND 5 and 10 ICHIMURA ET AL.
groups also showed early onset of abnormal estrous cycling starting at 19 wk of age, but the timing and pace of decline was clearly delayed compared to that of the PND0 group. In addition, diminishment of KiSS1 expression in the AVPV was also inversely correlated with age at exposure in both the realtime PCR and ISH analyses. These results clearly indicate that sensitivity of the neonatal brain to postnatal estrogen exposure could change with developmental stage and that the neonatal brain is more vulnerable at earlier developmental stage. On the other hand, a similar pattern of decline in estrous cycle in the PND 5 and 10 groups suggests that the sensitivity may not differ so much between these ages. Considering the slight 
earlier cessation of estrous cycling and slight decrease in KiSS1 expression in the PND14 group, it could be said that the critical window for delayed effects closes gradually along with progression of brain development during late postnatal ages.
Delayed effects are a growing concern because they might be overlooked in existing reproductive or developmental toxicity studies due to the limited observation period of these studies [8] . Therefore, it is toxicologically important to elucidate the mechanism of delayed effects, including identification of the critical window of sensitivity for the delayed effects. The perinatal period is well-known to be a crucial hormone-sensitive period during which the hypothalamus undergoes sexual differentiation [29] , and it has been generally estimated to be consistent with approximately late embryonic to early postnatal periods in rats [1, 22] . In detail, the critical period for CNS sexual differentiation has been classically considered to be 18-27 days after conception in rats [24, 25] . Therefore, if the gestation period is 21 days, Embryonic Day 18 to PND5 would be assumed to be the critical period of CNS sexual differentiation in rats. However, the results obtained from the present study indicate that neonatal brains maintain sensitivity to estrogens at least until PND10 and are still vulnerable to exogenous estrogens during late postnatal ages in rats. This period corresponds approximately to the third trimester of human gestation, when the hypothalamus is still undergoing sexual differentiation in humans [30, 31] . Maternal exposure to DES in human is widely known to cause serious adverse reproductive outcome such as increased risk of vaginal clear cell adenocarcinomas and various structural abnormalities of the genital tract in young women who are the so-called DES daughters [32, 33] . In many epidemiological researches of DES based on clinical data, Swan [33] reported that vaginal adenosis, a noncancerous abnormalities often seen in DESexposed women, was seen in 85% of those who had been exposed to DES by 14 wk gestation but in none of those first exposed after 22 wk (second trimester) of gestation. These results indicates the higher sensitivity of embryo/fetus to exogenous estrogens in the earlier period of gestation; however, our results in the present study also provides new insight about the potential risk of later-exposed estrogens to induce invisible influences such as development impairment of kisspeptin neuron. Though it is difficult to directly extrapolate the result in rats to human, at least our results may suggest that developing brains in human also have the possibility of maintaining sensitivity to estrogens longer than the expected period.
Regarding the endpoint of the critical window, very few reports have directly investigated and discussed the precise endpoint. Cruz and colleagues [34] reported that single exposure to 10 mg/kg EV in rats at PND 1, 7, or 14 caused permanent cessation of the estrus cycle and morphological changes in the ovary with multiple cystic structures, but exposure at PND21 and PND30 caused only a transient cessation, suggesting that the hormone-sensitive period in postnatal rats spanned the neonatalinfantile period. Regarding sensitivity at PND14, another publication from the same group reported that a single ICHIMURA ET AL. intramuscular injection of 2 mg EV at PND14 also induced decreased cycle frequency at PND70-PND90 in rats [23] . These previous findings indicate that the critical window in postnatal rats is still open at PND14; however, alteration of the estrous cycle and KiSS1 expression in the PND14 group was not apparent in the present study. Considering the extremely high dose of EV utilized in these studies, manifestation of the effects caused by the exposure at PND14 may require a much higher dose, and other experimental factors, such as chemicals, strains of rats, and timing of analysis, may also affect the results of the investigation. Conversely, the seemingly contradictory results for PND14 may indicate that sensitivity to estrogen exposure at PND14 is very weak but still maintained, and also support the hypothesis that the critical window for delayed effects closes gradually during the late postnatal ages with PND14 being a provisional endpoint for the window.
In the present study, we also found that postnatal exposure to EE at PND10 and PND14 could significantly accelerate VO. 
Early VO in response to perinatal exposure to higher levels of estrogenic compounds has been described in several articles [23, 28, 35, 36] . In these reports, various hypotheses of the mechanisms for the acceleration of VO are discussed, but the precise mechanism is still undetermined [36] . Lack of first ovulation on the day following premature VO in the present study suggests that the acceleration was not caused by the effect of postnatally exposed EE on the HPG axis, but instead was caused by the direct action of EE on the vagina. Enhancement of the sensitivity of the vagina to endogenous estrogen, which is responsible for natural VO, might be plausible, but the mechanism remains undetermined due to lack of supportive data on ERa expression in the vagina in the present study. Considering that acceleration of VO was observed only in the PND10 and PND14 groups, the late postnatal period might be more sensitive to the enhancing ICHIMURA ET AL. effect of EE than the neonatal period. Further investigation is needed for the elucidation of the true mechanism.
The present study clarifies the critical window of sensitivity for delayed effects induced by a single postnatal exposure to EE. Diminished KiSS1 expression, decreased number of KiSSpositive cells in the AVPV, and an attenuating trend of LH surge were observed at 11 wk of age in animals postnatally exposed to 20 lg/kg of EE at PND 0, 5, and 10. A corresponding early onset of abnormal estrous cycling was also observed in the same groups, but these serial changes were not evident in the animals exposed to EE at PND14. These results indicate that PND0-PND10 is the critical window of susceptibility for delayed effects in rat neonates, and PND14 is presumed to be a provisional endpoint of this window.
